-
Why GSK should turn down Unilever’s billions
News Unilever has offered GSK £50bn for its consumer division. But while the cash will be a temptation, the deal is not in the interests of shareholders or of anyone else, says Matthew Lynn.
News -
Unilever slides and GSK bounces after GSK knocks back £50bn bid
News Unilever shares fell to their lowest level in around five years, after its £50bn takeover bid for GSK’s consumer health unit was rejected.
News -
What London’s new share listing rules mean for your money
Briefings UK regulators hope that weaker listing rules will attract more tech listings and rejuvenate a declining stockmarket. Perhaps they should pay more attention to other growth sectors.
Briefings -
Two outstandingly cheap UK stocks in an age of mad valuations
Opinion In these times of nutty company valuations, there is still plenty of opportunity around, says Merryn Somerset Webb. Take these two stocks, for example.
Opinion -
Shell's move to London is a vote of confidence in Brexit Britain
Opinion Shell and Unilever have upped sticks and moved to the UK. The City should tempt more corporate giants in, says Matthew Lynn.
Opinion -
It’s time to buy British stocks
News The UK economy remains sluggish and still faces many headwinds. But things are looking brighter for British stocks.
News -
Post-pandemic recovery stocks run out of puff
Analysis The Covid-19 vaccines have been successful. Many plays on the global recovery have not done so well.
Analysis -
Private equity eyes up high-street banks
Opinion Carlyle’s bid for Metro may be just an appetiser before the hearty main course, says Matthew Lynn
Opinion -
Why have Asos shares tumbled today?
News UK retailer Asos issued a profit warning on Monday. Saloni Sardana breaks down what may be behind the move.
News
